Trial intelligence / Profile preview

Hospital Centralized Safety Monitoring of Guipi Mixture

ChiCTR2400085691Phase 4Recruiting

Sponsor
Anning City First People's Hospital
Start
Jun 2024
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of Guipi Decoction in sleep disorder, sponsored by Anning City First People's Hospital. Primary endpoint: Adverse drug events / Adverse drug reactions. Started Jun 2024; status: recruiting.

02

Drugs

Guipi Decoction
03

Conditions

sleep disorder

Beyond the preview

Go deeper on ChiCTR2400085691.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2400085691.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call